Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis

Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04662268

Enrollment

206

Registered

2020-12-10

Start date

2014-01-01

Completion date

2020-11-30

Last updated

2020-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Colitis

Keywords

Ischemic colitis, computed tomography

Brief summary

Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic colitis and therefore possibly modify the therapeutic management (propose surgical treatment for a severe form based on prognostic score).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \> or = at 18 years old; * Performing an abdomino-pelvic scan injected within 6 hours of the onset of symptoms; * Ischemic colitis proven by endoscopy or surgical data.

Exclusion criteria

* CT scan performed without injection and / or after 6 hours following the onset of symptoms; * Unproven ischemic colitis.

Design outcomes

Primary

Measure	Time frame	Description
Complication rate of ischemic colitis	1 day	Severe (surgery and/or death) or non severe form of ischemic colitis (medical treatment) : analysis of radiological, biological and clinical data is performed at the time of acute episode of ischemic colitis when the patient is admitted to the hospital or during the stay of the patient previously present in the hospital for another condition

Countries

France

Outcome results